Insights on the Iron Deficiency Anemia Market to 2022 | Industry Statistics, Emerging Demands, Forecast to 2028
The global iron deficiency anemia market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2022-2028). The increasing number of cases associated with haemodilution in pregnancy across the globe is one of the prime factors affecting and driving the market for iron deficiency anemia. Haemodilution generally occurs during pregnancy and the most common causes of anemia during pregnancy are iron deficiency and folate acid deficiency. Additionally, the changes in lifestyle which are more in developed and developing countries, are resulting in irregular BMI, and an increase in abnormal weight which in turn is disturbing the physiology of a pregnant woman impacting the market.
To Request a Sample of our Report on Iron Deficiency
Anemia Market: https://www.omrglobal.com/request-sample/iron-deficiency-anemia-market
Moreover, to gain on the opportunity key players operating
in the global iron deficiency anemia market had been adopting strategies such
as new launches to achieve major market share. For instance, in July 2021, one
of the divisions of Novartis AG that is Sandoz had introduced generic
Ferumoxytol in the US which is an intravenous medication used for the purpose
of treatment of iron deficiency anemia (IDA). Through this launch, the company
would continue to build its hospital and clinic portfolio along with offering
access to affordable generic medicines.
Market Coverage
• The
market number available for – 2021-2028
• Base year-
2021
• Forecast
period- 2022-2028
Segment Covered-
·
By Therapy Type
·
By End-User
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- AMAG Pharmaceuticals, Bayer
AG, Novartis AG, Sanofi, and Pieris Pharmaceuticals, Inc.
(Get 15% Discount on Buying this Report)
A
full Report of Iron Deficiency Anemia Market is Available @ https://www.omrglobal.com/industry-reports/iron-deficiency-anemia-market
Global Iron Deficiency Anemia Market Report Segment
By Therapy Type
•
Intravenous Iron Therapy
•
Oral Iron Therapy
•
Red Blood Cell Transfusion
•
Others
By End-User
•
Hospitals & Clinics
•
Home Healthcare
Global Iron Deficiency Anemia Market Report Segment by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Company Profiles
·
Akebia Therapeutics, Inc.
·
AMAG Pharmaceuticals
·
Bayer AG
·
Fe3 Medical Inc.
·
Iron4u Aps
·
LUITPOLD PHARMACEUTICALS, INC.
·
Novartis AG
·
Pieris Pharmaceuticals, Inc.
·
Pharmacosmos A/S.
·
Renibus Therapeutics Inc.
·
Rockwell Medical, Inc.
·
Sanofi
·
Shield Therapeutics plc
·
Vifor Pharma Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment